NORTH TONAWANDA, N.Y., April 8, 2011 /PRNewswire/ -- VIGILAIR Systems, an industry leader in Ultraviolet Germicidal Irradiation (UVGI) technology was instrumental in a newly published, and first of its kind hospital study that demonstrated a dramatic reduction in patient Hospital Acquired Infections (HAI) with the application of VIGILAIR® air cleaning technology in a Neonatal Intensive Care Unit (NICU).
The published article 'Effect of enhanced ultraviolet germicidal irradiation in the heating ventilation and air conditioning system on ventilator associated pneumonia in a neonatal intensive care unit' appears in the April 2011 on-line edition of Journal of Perinatology (www.nature.com/jp). The study was conducted by Attending Physicians in the NICU of Women and Children's Hospital of Buffalo, located in Buffalo, NY, a University affiliated Regional Perinatal Center. This work was supported in part by a grant from the NYSTAR Center for Advanced Technology in Biomedical and Bioengineering by the Department of Pediatrics SUNY at Buffalo.
Results demonstrated a reduction of Ventilator Associated Pneumonia (VAP) by 50% in the most high risk population; NICU surface contamination reduction greater than 99.99%; Tracheal microbial colonization reduction by 45%; Antibiotic usage reduction by 62%; and an estimated annual clinical savings of greater than $500,000.
The air purification equipment, referred to as Enhanced Ultra Violet Germicidal Irradiation (e-UVGI), also known as a Pathogen Control System (PCS), was supplied by VIGILAIR Systems.
"This is, to our knowledge, the first published study of its kind," said Peter Bjorkman, President at VIGILAIR Systems, Inc. "The results show clearly how important the HVAC system is as a contamination source in sensitive environments like hospitals. The findings in this study correspond well with other studies VIGILAIR has been involv
|SOURCE VIGILAIR Systems, Inc.|
Copyright©2010 PR Newswire.
All rights reserved